At what enterprise value was ALERIS acquired in 2019?

During the acquisition of ALERIS by TRITON PARTNERS in 2019, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b SEK. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of ALERIS when it was acquired by TRITON PARTNERS?

The estimated EV/EBITDA multiple for ALERIS is in the range of 15x - 25x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was ALERIS acquired by TRITON PARTNERS?

ALERIS was acquired by TRITON PARTNERS in 2019.

What was the revenue of ALERIS at the time of the deal?

The revenue of ALERIS at the time of the deal is estimated to be in the range of 5b - 100b SEK. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of ALERIS during the acquisition?

ALERIS's EBITDA is estimated to be in the range of 100M - 200M SEK. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the ALERIS acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ALERIS deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.unquote.com/nordics/official-record/3015720/triton-buys-aleris-for-sek-28bn

← DATABASE

Home Database Healthcare & PharmaALERIS

07/2019

ALERIS acquired by TRITON PARTNERS

SWEDEN Health Providers / Healthcare Facilities / Clinics / Hospitals EV 1b - 4b SEK

Context

Triton Partners acquired a controlling majority stake in Aleris Group from Patricia Industries in a significant Nordic healthcare transaction. The deal was structured via a definitive share purchase agreement and funded primarily through equity drawn from the Triton Fund V, a flagship vehicle that finalized fundraising at €5 billion in January 2019. Under the binding terms of the carve-out agreement, the digital healthcare platform entity Doktor24 was explicitly excluded from the perimeter and remained under the ownership of Patricia Industries. The transaction immediately transitioned Aleris into Triton’s healthcare portfolio, providing the asset with substantial institutional backing and capital reserves to fund downstream digital infrastructure updates and target localized clinical bolt-on acquisitions.

ALERIS, which reported an EBITDA margin of in 2019, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Aleris Group is a premier Scandinavian healthcare provider specializing in high-quality elective surgery, outpatient mental health services, and medical diagnostics. Headquartered in Stockholm, Sweden, the company operates via a multi-payer economic model, serving roughly millions patient visits annually through public healthcare system allocations, private health insurance programs, and out-of-pocket direct payments. The organization runs a unified network of approximately +100 clinics and hospitals staffed by +5,000 specialized medical professionals across Sweden, Norway, and Denmark. Strategically, the firm acts as a dominant, high-equity clinical complement to publicly funded healthcare systems, utilizing advanced digital infrastructure to streamline outpatient care pathways.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (SEK)

Year

Rev

EBITDA

EBIT

2019

2018

Other operations with ALERIS

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
05/2026	MEHILÄINEN GROUP	ALERIS	SWEDEN	Clinics / Hospitals

REFERENCES

Valuation range: EV 1b - 4b SEK

Revenue range: 5b - 100b SEK

EBITDA range: 100M - 200M SEK

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ALERIS by TRITON PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: triton partners